Prolonged response to vismodegib in a patient with systemic medulloblastoma metastases | BMJ Case Reports

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Global health

Authors

About

Help
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Unexpected outcome (positive or negative) including adverse drug reactions

Case report

Prolonged response to vismodegib in a patient with systemic medulloblastoma metastases

Online download statistics by month:

Online download statistics by month: October 2020 to March 2023

	Abstract	Full	Pdf
Oct 2020	179	18	4
Nov 2020	629	13	8
Dec 2020	262	6	1
Jan 2021	119	10	6
Feb 2021	65	4	1
Mar 2021	76	3	1
Apr 2021	62	2	0
May 2021	33	4	1
Jun 2021	8	2	0
Jul 2021	4	4	2
Sep 2021	3	0	0
Oct 2021	49	0	0
Nov 2021	67	1	0
Dec 2021	32	0	1
Jan 2022	30	1	0
Feb 2022	83	0	0
Mar 2022	51	0	0
Apr 2022	42	1	0
May 2022	76	1	1
Jun 2022	21	1	0
Jul 2022	43	4	0
Aug 2022	41	1	0
Sep 2022	33	1	2
Oct 2022	61	0	0
Nov 2022	12	1	0
Dec 2022	25	1	1
Jan 2023	23	0	0
Feb 2023	80	5	1
Mar 2023	37	1	1
Total	2246	85	31